← 研踪 PaperTrailarXiv:2611.15710 · v1
Curiosity-0826-4B: Generative Medical Event Sequence Modeling Across Pediatric and Adult Populations
首次提交 2026-11-12 00:53
版本更新 2026-11-12 00:53
雷达观测 2026-11-13 14:16
摘要
We introduce Curiosity-0826-4B, an updated version of the generative medical event foundation model trained on Epic Cosmos that simulates patient timelines to produce zero-shot clinical predictions. Curiosity-0826-4B incorporates a broader patient population and richer clinical event representations, while generally matching or exceeding Curiosity-0226-1B, the largest model in the previous Curiosity-0226 series, on evaluated tasks supported by both models. Laboratory value prediction improved, with MAE 18--46% lower than that of Curiosity-0226-1B. We evaluated prediction of disease events across pediatric cohorts aged 2--17 years. AUROCs for new asthma diagnosis (0.742--0.785) and asthma exacerbation (0.829--0.852) were comparable to those in the adult reference cohort, while AUROCs for sickle cell crisis (0.820--0.847) were lower than in adults (0.915). Explicit representation of documented death enabled new mortality prediction tasks among adults across hospice, inpatient, and ambulatory settings (AUROC 0.821--0.942). Scaling-law analysis guided compute-optimal initial pretraining followed by continued pretraining with context extension. The resulting Curiosity-0826-4B model has more parameters (4.3B versus 1B) and a longer context window (16K versus 8K). It processes 56% fewer training tokens and requires 2.2 times the training floating point operations (FLOPs) compared with its predecessor. By extending a common zero-shot prediction strategy to pediatric patients and additional outcomes, Curiosity-0826-4B broadens opportunities to develop clinical and operational applications without training separate task-specific models. Further validation should assess local calibration, performance across patient subgroups and event frequencies, timeline completion rates, and generalization to new settings, alongside prospective evaluation of clinical and operational utility.
观测到的版本
相邻记录可能跳过中间版本；首次发现 v2 及以上也会标为版本更新。
v1 · 2026-11-12 00:53 · 最新观测版本
Curiosity-0826-4B: Generative Medical Event Sequence Modeling Across Pediatric and Adult Populations
We introduce Curiosity-0826-4B, an updated version of the generative medical event foundation model trained on Epic Cosmos that simulates patient timelines to produce zero-shot clinical predictions. Curiosity-0826-4B incorporates a broader patient population and richer clinical event representations, while generally matching or exceeding Curiosity-0226-1B, the largest model in the previous Curiosity-0226 series, on evaluated tasks supported by both models. Laboratory value prediction improved, with MAE 18--46% lower than that of Curiosity-0226-1B. We evaluated prediction of disease events across pediatric cohorts aged 2--17 years. AUROCs for new asthma diagnosis (0.742--0.785) and asthma exacerbation (0.829--0.852) were comparable to those in the adult reference cohort, while AUROCs for sickle cell crisis (0.820--0.847) were lower than in adults (0.915). Explicit representation of documented death enabled new mortality prediction tasks among adults across hospice, inpatient, and ambulatory settings (AUROC 0.821--0.942). Scaling-law analysis guided compute-optimal initial pretraining followed by continued pretraining with context extension. The resulting Curiosity-0826-4B model has more parameters (4.3B versus 1B) and a longer context window (16K versus 8K). It processes 56% fewer training tokens and requires 2.2 times the training floating point operations (FLOPs) compared with its predecessor. By extending a common zero-shot prediction strategy to pediatric patients and additional outcomes, Curiosity-0826-4B broadens opportunities to develop clinical and operational applications without training separate task-specific models. Further validation should assess local calibration, performance across patient subgroups and event frequencies, timeline completion rates, and generalization to new settings, alongside prospective evaluation of clinical and operational utility.
查看此版本解读 →查看此版本原文 ↗